LMNA and laminopathy: Of note, rapamycin has been shown to reverse elevated mTORC1 signaling in lamin A/C-deficient mice, showing that a direct effect of the drug on the m-TOR pathway is beneficial not only in progeroid, but even in muscle laminopathies [52].